FcRn Rescues Recombinant Factor VIII Fc Fusion Protein from a VWF Independent FVIII Clearance Pathway in Mouse Hepatocytes
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FcRn Rescues Recombinant Factor VIII Fc Fusion Protein from a VWF Independent FVIII Clearance Pathway in Mouse Hepatocytes
Authors
Keywords
-
Journal
PLoS One
Volume 10, Issue 4, Pages e0124930
Publisher
Public Library of Science (PLoS)
Online
2015-04-24
DOI
10.1371/journal.pone.0124930
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A conditional knockout mouse model reveals endothelial cells as the principal and possibly exclusive source of plasma factor VIII
- (2014) S. A. Fahs et al. BLOOD
- Murine coagulation factor VIII is synthesized in endothelial cells
- (2014) L. A. Everett et al. BLOOD
- Recombinant factor VIII Fc fusion protein: extended-interval dosing maintains low bleeding rates and correlates with von Willebrand factor levels
- (2014) A. D. Shapiro et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy
- (2013) D. Lillicrap BLOOD
- A novel B-domain O-glycoPEGylated FVIII (N8-GP) demonstrates full efficacy and prolonged effect in hemophilic mice models
- (2013) H. R. Stennicke et al. BLOOD
- The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels
- (2013) N. Rydz et al. BLOOD
- Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A
- (2013) J. Mahlangu et al. BLOOD
- von Willebrand factor contributes to longer half-life of PEGylated factor VIIIin vivo
- (2013) L. Tang et al. HAEMOPHILIA
- Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogs
- (2012) J. A. Dumont et al. BLOOD
- Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients
- (2012) J. S. Powell et al. BLOOD
- Macrophage LRP1 contributes to the clearance of von Willebrand factor
- (2012) G. Rastegarlari et al. BLOOD
- Cross-presentation of IgG-containing immune complexes
- (2012) Kristi Baker et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Intravascular recovery of VWF and FVIII following intraperitoneal injection and differences from intravenous and subcutaneous injection in mice
- (2012) Q. SHI et al. HAEMOPHILIA
- Contribution of platelet vs. endothelial VWF to platelet adhesion and hemostasis
- (2012) S. KANAJI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Biochemical and functional characterization of a recombinant monomeric factor VIII-Fc fusion protein
- (2012) R. T. PETERS et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Modern haemophilia care
- (2012) Erik Berntorp et al. LANCET
- Monoclonal antibodies directed against human FcRn and their applications
- (2012) Gregory J. Christianson et al. mAbs
- Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels
- (2011) Guillemette Antoni et al. BMC Medical Genetics
- Strategies for extended serum half-life of protein therapeutics
- (2011) Roland E Kontermann CURRENT OPINION IN BIOTECHNOLOGY
- Neonatal Fc receptor and IgG-based therapeutics
- (2011) Timothy T. Kuo et al. mAbs
- The transfer of maternal antigen-specific IgG regulates the development of allergic airway inflammation early in life in an FcRn-dependent manner
- (2010) Kyosuke Nakata et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Prolonged activity of factor IX as a monomeric Fc fusion protein
- (2010) R. T. Peters et al. BLOOD
- Rational design of a fully active, long-acting PEGylated factor VIII for hemophilia A treatment
- (2010) B. Mei et al. BLOOD
- Novel Associations of Multiple Genetic Loci With Plasma Levels of Factor VII, Factor VIII, and von Willebrand Factor
- (2010) Nicholas L. Smith et al. CIRCULATION
- Factor VIII and von Willebrand factor - too sweet for their own good
- (2010) P. J. LENTING et al. HAEMOPHILIA
- Neonatal Fc Receptor: From Immunity to Therapeutics
- (2010) Timothy T. Kuo et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Characterization of two F4/80-positive Kupffer cell subsets by their function and phenotype in mice
- (2010) Manabu Kinoshita et al. JOURNAL OF HEPATOLOGY
- The “normal” factor VIII concentration in plasma
- (2010) Saulius Butenas et al. THROMBOSIS RESEARCH
- Laboratory Diagnosis and Molecular Classification of von Willebrand Disease
- (2009) Alain Gadisseur et al. ACTA HAEMATOLOGICA
- An FcRn-Dependent Role for Anti-flagellin Immunoglobulin G in Pathogenesis of Colitis in Mice
- (2009) Kanna Kobayashi et al. GASTROENTEROLOGY
- Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance
- (2009) V. TERRAUBE et al. HAEMOPHILIA
- Splenic marginal zone antigen-presenting cells are critical for the primary allo-immune response to therapeutic factor VIII in hemophilia A
- (2009) A. NAVARRETE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Bio-distribution of pharmacologically administered recombinant factor VIIa (rFVIIa)
- (2009) R. GOPALAKRISHNAN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Conditional deletion of the MHC class I-related receptor FcRn reveals the sites of IgG homeostasis in mice
- (2009) Héctor Pérez Montoyo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Macrophages contribute to the cellular uptake of von Willebrand factor and factor VIII in vivo
- (2008) C. J. van Schooten et al. BLOOD
- The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer
- (2008) E Wisse et al. GENE THERAPY
- The disappearing act of factor VIII
- (2008) P. J. LENTING et al. HAEMOPHILIA
- Dependence of antibody-mediated presentation of antigen on FcRn
- (2008) S.-W. Qiao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started